31
Participants
Start Date
April 1, 2017
Primary Completion Date
February 4, 2019
Study Completion Date
February 4, 2019
TLC399 (ProDex)
2-vial system: TLC399-DSP and TLC399-Lipid
Retina Associates of Western New York, PC, Rochester
University of Virginia, Charlottesville
Charlotte Eye Ear Nose & Throat Assoc, PA, Charlotte
Georgia Retina, P.C, Marietta
Retina Macula Specialists of Miami, Miami
The Cleveland Clinic, Cleveland
Retina Consultants of Houston, Houston
Retina Consultants of Houston,The Woodlands, The Woodlands
Medical Center Ophthalmology Associates, San Antonio
Retinal Consultants of San Antonio, San Antonio
Retina Research Center, Austin
Retina Research Institute of Texas, Abilene
Colorado Retina Associates, Golden
Retinal Research Institute, Phoenix
Retina Consultants of Nevada, Las Vegas
Retina-Vitreous Associates Medical Group, Beverly Hills
Retina Institute of California, Arcadia
Retina Institute of California, Palm Desert
Retina Group of New England, New London
Ophthalmic Consultants of Boston, Boston
Lead Sponsor
Taiwan Liposome Company
INDUSTRY